What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Disease
His primary scientific interests are in Internal medicine, Endocrinology, Cholesterol, Odds ratio and Prospective cohort study.
His Internal medicine research is multidisciplinary, relying on both Population study and Cardiology.
His Endocrinology research includes themes of Mendelian randomization and Risk factor.
His Cholesterol study deals with C-reactive protein intersecting with Rosuvastatin Calcium and Rosuvastatin.
His Odds ratio study also includes
- Genome-wide association study, Single-nucleotide polymorphism and Prostate cancer most often made with reference to Oncology,
- Breast cancer and related Case-control study and TOX3.
Børge G. Nordestgaard interconnects Arteriosclerosis, Proportional hazards model, Cohort study and Mendelian Randomization Analysis in the investigation of issues within Prospective cohort study.
His most cited work include:
- Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. (4538 citations)
- Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein (3523 citations)
- Genome-wide association study identifies novel breast cancer susceptibility loci (2045 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Endocrinology, Population study, Hazard ratio and Odds ratio are his primary areas of study.
His Internal medicine research integrates issues from Oncology and Cardiology.
His Endocrinology study frequently links to related topics such as Risk factor.
Børge G. Nordestgaard combines subjects such as Gastroenterology, COPD, Cohort study and Body mass index with his study of Population study.
His Hazard ratio study combines topics from a wide range of disciplines, such as Proportional hazards model, Prospective cohort study and Surgery.
As a part of the same scientific family, Børge G. Nordestgaard mostly works in the field of Odds ratio, focusing on Mendelian randomization and, on occasion, Mendelian Randomization Analysis and Confounding.
He most often published in these fields:
- Internal medicine (104.91%)
- Endocrinology (31.67%)
- Population study (37.44%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (104.91%)
- Population study (37.44%)
- Hazard ratio (30.25%)
In recent papers he was focusing on the following fields of study:
Børge G. Nordestgaard mainly investigates Internal medicine, Population study, Hazard ratio, Cholesterol and Myocardial infarction.
Børge G. Nordestgaard has researched Internal medicine in several fields, including Endocrinology, Oncology and Cardiology.
His work in the fields of Endocrinology, such as Very low-density lipoprotein and Diabetes mellitus, intersects with other areas such as Context.
The concepts of his Population study study are interwoven with issues in Body mass index, Cohort study, Gastroenterology, Confidence interval and Disease.
His Hazard ratio research focuses on Prospective cohort study and how it relates to Epidemiology.
The study incorporates disciplines such as Stroke, Statin, Interquartile range and Number needed to treat in addition to Myocardial infarction.
Between 2018 and 2021, his most popular works were:
- Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (257 citations)
- Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (257 citations)
- Lipoprotein(a) Reduction in Persons with Cardiovascular Disease. (142 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
Børge G. Nordestgaard mainly focuses on Internal medicine, Population study, Myocardial infarction, Lipoprotein and Cholesterol.
His Internal medicine research incorporates elements of Gastroenterology and Oncology.
Børge G. Nordestgaard interconnects Blood pressure, FEV1/FVC ratio, Number needed to treat, Systemic inflammation and Confounding in the investigation of issues within Population study.
His Myocardial infarction research includes themes of Stroke, Lower risk, Confidence interval and Biomarker.
His study in Lipoprotein is interdisciplinary in nature, drawing from both Risk factor and Apolipoprotein B.
His Cholesterol study contributes to a more complete understanding of Endocrinology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
